Since its establishment in 1997, MAIDE MEDICAL Group has become a major driver in the global healthcare industry. With its deep expertise in medical device research and development and stem cell technology, it continues to lead innovation and breakthroughs in global medical technology. Headquartered in the UK, the group’s influence extends worldwide, with subsidiaries in Russia, Germany, Hong Kong, and the Netherlands. In November and December 2024, the group will further expand its global footprint by opening new research institutes in Turkey and Brazil.
A Pioneer in Stem Cell Technology
Founded in 2005, MAIDE MEDICAL Group’s stem cell research institute symbolizes the group’s significant achievements in stem cell technology. The institute brings together top experts from around the world and is equipped with cutting-edge equipment from Switzerland and Germany. It is dedicated to advancing the application of stem cell technology in clinical treatment and research. By collaborating with over 200 leading hospitals globally, the group actively promotes clinical research and application of stem cells, bringing new hope to human health.
Stem cell technology has been applied to the treatment of numerous medical challenges, and MAIDE MEDICAL Group remains at the forefront of the industry, breaking through the barriers of traditional medicine. Today, the group covers over 60% of the top ten international stem cell banks, providing strong support for medical research and treatment.
Outstanding Products and Services
In addition to stem cell technology, MAIDE MEDICAL Group has also achieved significant success in the field of medical device development. To date, the group has launched more than 200,000 large-scale precision medical devices, widely used in medical institutions worldwide. These instruments provide doctors and researchers with accurate and reliable diagnostic and treatment tools, improving the quality of medical services and offering more efficient treatment options for patients globally.
At the same time, MAIDE MEDICAL Group has provided high-end medical services to over 5 million families, earning the trust and praise of users worldwide through its excellent product quality and professional service system.
Global Collaboration and Innovation Model
As a leader in global medical technology, MAIDE MEDICAL Group not only focuses on product and technological innovation but also strives to advance healthcare technology through global cooperation. The group maintains close collaborations with top hospitals and research institutions worldwide, continually pushing for breakthroughs and innovation in the field of stem cell technology.
To make high-end medical services more accessible, MAIDE MEDICAL Group introduced an internet-based innovative entrepreneurial model in 2019. This model allows global investors and entrepreneurs to participate in medical technology innovation. This innovation has not only brought capital and resources to the company but has also provided investors with substantial returns.
The group’s entrepreneurial model has gained widespread support from global investors and has helped further popularize precision medical instruments and stem cell technology. MAIDE MEDICAL Group adheres to the philosophy of “making high-end healthcare more accessible for major diseases” and is committed to enabling more people to benefit from high-end medical services, while achieving a win-win situation of “maximizing returns for investors.”
The entire MAIDE MEDICAL Group staff upholds the belief in “protecting the source of life and health.” From driving global healthcare technology advancements to helping patients receive better treatment options, MAIDE MEDICAL Group will continue to contribute to the cause of human health.
